3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
13
Rectal Neoplasms
4
Neoplasm Metastasis
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Advanced Solid Tumors
2
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma, Ewing
1
Sarcoma
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasms
1
Microsatellite-stable Colorectal Cancer
1
Metastatic Gastric Adenocarcinoma
1
Lung Neoplasms
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Endometrial Neoplasms
1
Desmoid Tumors
1
Craniopharyngioma
1
Colorectal Cancer Metastatic
1
Breast Neoplasms
1
Anal Cancer Metastatic
1
Advanced Microsatellite Stable Colorectal Cancer
1
Adenomatous Polyposis Coli
1
Interventions
Oxaliplatin
9
Capecitabine
9
pembrolizumab
7
Paclitaxel
7
Fluorouracil
7
Leucovorin
6
Cisplatin
6
zolbetuximab
5
Gemcitabine
4
trastuzumab deruxtecan
3
enzalutamide
3
durvalumab
3
cemiplimab
3
Trastuzumab
3
Pemetrexed
3
Docetaxel
3
Carboplatin
3
130-nm albumin-bound paclitaxel
3
fludarabine
2
darolutamide
2
Taxes
2
Ramucirumab
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Nivolumab
2
Irinotecan
2
Cyclophosphamide
2
Androgen Antagonists
2
Albumin-Bound Paclitaxel
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
trifluridine tipiracil drug combination
×
90 days
×
Clear all
No trials found.